Assessment of COVID-19 progression on day 5 from symptoms onset
Elisa Gentilotti(University of Verona), Evelina Tacconelli(University of Verona), Dario Meneghin(University of Verona), Sara Mehrabi(University of Verona), Domenico Girelli(University of Verona), Elisa Razzaboni(University of Verona), Anna M. Górska(University of Verona), Claudio Micheletto, Alessandro Visentin(University of Verona), Monica Compri(University of Verona), Elda Righi(Ospedale Santa Maria della Misericordia di Udine), Nicola Soriolo(University of Verona), Giorgia Be(University of Verona), Alessia Savoldi(University of Verona), Pasquale De Nardo(University of Verona)
Cited by 15
Related Papers
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
|The Lancet Infectious Diseases|2025|526
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>
|Clinical Infectious Diseases|2018|351